Oct 25, 2007 by Billy FisherDueling Fools: Blue Nile BullThe online jeweler's customer-friendly buying experience has succeeded in making the company a financial success.
Oct 25, 2007 by Billy FisherDueling Fools: Blue Nile Bull RebuttalBlue Nile's business model leaves it well protected if an economic downturn hits.
Oct 22, 2007 by Billy FisherAn Unwavering Approach at UnitedHealth GroupUnitedHealth Group repurchases $2 billion of shares during Q3 and is targeting full-year EPS growth of 18%.
Oct 19, 2007 by Billy FisherWyeth's ResilienceThe company reports solid results from all of its businesses, along with a 9% increase in sales.
Oct 19, 2007 by Billy FisherDefying Intuition at Intuitive SurgicalAnother round of good results brings another boost in the stock price.
Oct 19, 2007 by Billy FisherKeeping Pace at St. JudeSt. Jude has a strong quarter, but investors weren't impressed.
Oct 18, 2007 by Billy FisherAn Empire Strykes BackStryker reports a quarter of double-digit growth in revenue and earnings.
Oct 18, 2007 by Billy FisherAltria Lights UpThe tobacco giant's Q3 earnings beat Wall Street's estimates.
Oct 18, 2007 by Billy FisherStill Sleepless at ArenaThe drug company posts a wider Q3 loss than a year ago.
Oct 16, 2007 by Billy FisherA Heartbreaker at MedtronicThe medical device maker halts distribution of certain defibrillator wires.
Oct 16, 2007 by Billy FisherForest Labs Isn't Out of the Woods YetIts Q2 profit falls, but the company raises its full-year forecast.
Oct 12, 2007 by Billy FisherDueling Fools: Johnson & Johnson BearAn impressive company that may have its best days behind it.
Oct 12, 2007 by Billy FisherDueling Fools: Johnson & Johnson Bear RebuttalSometimes size can weigh you down.
Oct 11, 2007 by Billy FisherAn IPO That Hit the Bull's-EyeSirtris Pharmaceuticals presents promising drug data and enjoys an upswing in the volatile biopharma sector.
Oct 10, 2007 by Billy FisherMonsanto's Monster YearThe corn craze has created cash, but will it last?
Oct 9, 2007 by Billy FisherThe Full-Flavored Quarter of Yum! BrandsYum! Brands sees double-digit sales growth in Q3.
Oct 8, 2007 by Billy Fisher5 Stocks Choking in OctoberA look at former five-star stocks that have declined in the past 30 days.
Oct 8, 2007 by Billy FisherWheeling and Dealing at WyethWyeth acquires Haptogen and plans to submit an NDA to the FDA.
Oct 8, 2007 by Billy FisherA Menace to Big PharmaAbraxis gets tentative approval for a generic version of Pfizer's Camptosar.
Oct 8, 2007 by Billy FisherMcKesson Expands Its EmpireA new acquisition strengthens the company's presence in the cancer drug market.
